CURRENT REPORT UNDER SECTION 17 OF THE SECURITIES REGULATION CODE AND SRC RULE 17.2(c) THEREUNDER
1. Date of Report (Date of earliest event reported)
Jul 31, 2024
2. SEC Identification Number
808
3. BIR Tax Identification No.
000-162-935
4. Exact name of issuer as specified in its charter
Dito CME Holdings Corp.
5. Province, country or other jurisdiction of incorporation
Philippines
6. Industry Classification Code(SEC Use Only)
7. Address of principal office
21st Floor, Udenna Tower, Rizal Drive corner 4th Avenue, Bonifacio Global City, Taguig CityPostal Code1634
8. Issuer's telephone number, including area code
0284034007
9. Former name or former address, if changed since last report
N/A
10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA
Title of Each Class
Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
Common
19,535,000,000
11. Indicate the item numbers reported herein
Item 9
The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.
DITO CME Holdings Corp.DITO
PSE Disclosure Form 4-24 - Results of Annual or Special Stockholders' Meeting References: SRC Rule 17 (SEC Form 17-C) and Section 4.4 of the Revised Disclosure Rules
Subject of the Disclosure
Results of the Annual Stockholders' Meeting of DITO held on 31 July 2024.
Background/Description of the Disclosure
DITO held its Annual Stockholders' Meeting on 31 July 2024 via videoconferencing.
List of elected directors for the ensuing year with their corresponding shareholdings in the Issuer
Name of Person
Shareholdings in the Listed Company
Nature of Indirect Ownership
Direct
Indirect
Dennis A. Uy
6,375,323
4,993,456,650
Through Udenna Corporation
Donald Patrick L. Lim
30,000
0
-
Cherylyn C. Uy
10,000
1,426,243,350
-
Eric O. Recto
890,615
1,000,000
Through Monfortino Holdings Inc.
Raouf A. Kizilbash
1
0
-
Jonathan L. Ravelas
5,000
0
-
Enrico S. Cruz
100
0
-
Salvador C. Medialdea
1,000
0
-
External auditor
Sycip Gorres Velayo & Co.
List of other material resolutions, transactions and corporate actions approved by the stockholders
The stockholders approved the following agenda items:
1.Review and Approval of the Minutes of the Previous Meeting held on 5 July 2023 2.Approval of the Audited Financial Statements for 2023 3.Ratification of Acts of the Board of Directors and Management since the Last Annual Stockholders’ Meeting held on 5 July 2023 4.Election of Directors (including independent directors) 5.Amendment of the Corporation’s By Laws a.Amending Article II-A, Section 1 b.Amending Article III, Section 2 c.Amending Article III, Section 6 6.Approval of authority to act as surety and/or guarantor for its subsidiaries at the terms and conditions approved by the Board of Directors 7.Approval of issuance of shares pursuant to an equity offering, private placement, top-up placement or similar transaction to be determined by the Board and the listing of such shares. 8.Waiver by the majority of the minority shareholders present or represented during the meeting of the conduct of a rights or public offering, if necessary, under Part A, Article 5 of the PSE Revised Listing Rules (in relation to item 7) 9.Appointment of external auditor
All agenda items were approved by more than a majority of the stockholders present and represented during the meeting. For item 7, a majority vote of the minority shareholders present or represented during the meeting also approved afterwards the waiver of the conduct of a rights or public offering, if necessary, under Part A, Article 5 of the PSE Revised Listing Rules.
Other Relevant Information
Messrs. Cruz and Ravelas and Atty. Medialdea were elected as independent directors.
The details of the issuance of shares pursuant to an equity offering, private placement, top-up placement or similar transaction, are still to be determined subject to the approval of the Board of Directors.